Recently, the American Principles Project released a report finding that the market for transgender drugs and surgeries was worth $4.4 billion in 2023. The report also found that some transgender surgery providers were making more than $100 million in revenue annually.

The financial interests at stake for providers of puberty blockers, cross-sex hormones, and surgeries should raise even more caution.